Rentokil Initial Plc /Fi (RKLIF) Cash & Equivalents (2020 - 2026)

Rentokil Initial (RKLIF) has reported Cash & Equivalents for 7 consecutive years, with $2.5 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash & Equivalents rose 46.3% year-over-year to $2.5 billion; the TTM figure through Jun 2026 stood at $2.5 billion (up 46.3% YoY), while the FY2025 annual figure was $2.3 billion, up 100.26% from the prior year.
• Cash & Equivalents rose to $2.5 billion in Q2 2026 per RKLIF's latest filing, from $2.3 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $2.5 billion in Q2 2026 and bottomed at $6.0 million in Q3 2025.
• Historically, Cash & Equivalents has averaged $1.3 billion across 5 years, with a median of $1.4 billion in 2025.
• Annual changes were most pronounced in 2023 — Cash & Equivalents slumped 98.19% — and 2024, when it soared 5387.74%.
• Rentokil Initial's Cash & Equivalents stood at $1.0 billion in 2022, then plunged by 98.19% to $18.6 million in 2023, then jumped by 5387.74% to $1.0 billion in 2024, then surged by 126.98% to $2.3 billion in 2025, then grew by 6.55% to $2.5 billion in 2026.
• Business Quant data shows RKLIF's Cash & Equivalents at $2.5 billion in Q2 2026, $2.3 billion in Q4 2025, and $6.0 million in Q3 2025.